TotalMarketCap

Vicore Pharma Holding AB

VCRENasdaq SwedenHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.953 B

$10.49 +9.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Vicore Pharma Holding AB (VCRE) has a market capitalization of $2.95B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #75Bausch Health CompaniesBHC$2.99B
  2. #76IDEAYA BiosciencesIDYA$2.97B
  3. #77Vicore Pharma Holding ABVCRE$2.95B
  4. #78XencorXNCR$2.56B
  5. #79Arcus BiosciencesRCUS$2.55B

What if Vicore Pharma Holding AB were worth as much as…

Open the what-if tool →

Gold $28.2T

$100,299.49

Per share 9,561× higher

Bitcoin $1.53T

$5,427.03

Per share 517× higher

Apple $5.02T

$17,816.44

Per share 1,698× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Vicore Pharma Holding AB are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.